Skip to main content

Research Repository

Advanced Search

SRC3 Phosphorylation at Serine 543 Is a Positive Independent Prognostic Factor in ER-Positive Breast Cancer

Zwart, W.; Flach, K. D.; Rudraraju, B.; Abdel-Fatah, T. M. A.; Gojis, O.; Canisius, S.; Moore, D.; Nevedomskaya, E.; Opdam, M.; Droog, M.; Hofland, I.; Chan, S.; Shaw, J.; Ellis, I. O.; Coombes, R. C.; Carroll, J. S.; Ali, S.; Palmieri, C.

Authors

W. Zwart

K. D. Flach

B. Rudraraju

T. M. A. Abdel-Fatah

O. Gojis

S. Canisius

D. Moore

E. Nevedomskaya

M. Opdam

M. Droog

I. Hofland

SUE CHAN Sue.Chan@nottingham.ac.uk
Associate Professor

J. Shaw

R. C. Coombes

J. S. Carroll

S. Ali

C. Palmieri



Citation

Zwart, W., Flach, K. D., Rudraraju, B., Abdel-Fatah, T. M. A., Gojis, O., Canisius, S., …Palmieri, C. (2016). SRC3 Phosphorylation at Serine 543 Is a Positive Independent Prognostic Factor in ER-Positive Breast Cancer. Clinical Cancer Research, 22(2), 479-491. https://doi.org/10.1158/1078-0432.ccr-14-3277

Journal Article Type Article
Acceptance Date Aug 8, 2015
Online Publication Date Sep 14, 2015
Publication Date Jan 15, 2016
Deposit Date Dec 6, 2018
Journal Clinical Cancer Research
Print ISSN 1078-0432
Electronic ISSN 1557-3265
Publisher American Association for Cancer Research
Peer Reviewed Peer Reviewed
Volume 22
Issue 2
Pages 479-491
DOI https://doi.org/10.1158/1078-0432.ccr-14-3277
Public URL https://nottingham-repository.worktribe.com/output/1371415
Publisher URL http://clincancerres.aacrjournals.org/content/22/2/479